Clinical trial

NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

NCT06066437

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-03-29

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2024-03-29Date precision: day

Registry last updated2026-07-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Arm A: 177Lu rhPSMA-10.1DRUG

Arm B: 177Lu rhPSMA-10.1 plus DegarelixDRUG

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

Blue Earth Therapeutics Ltdcollaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06066437 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.